DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Pirprofen

Pirprofen

  • United States Patent (19) 11 Patent Number: 5,955,504 Wechter Et Al

    United States Patent (19) 11 Patent Number: 5,955,504 Wechter Et Al

  • What Are the Acute Treatments for Migraine and How Are They Used?

    What Are the Acute Treatments for Migraine and How Are They Used?

  • (12) United States Patent (10) Patent No.: US 6,472,433 B2 Wechter (45) Date of Patent: Oct

    (12) United States Patent (10) Patent No.: US 6,472,433 B2 Wechter (45) Date of Patent: Oct

  • Treatment for Acute Pain: an Evidence Map Technical Brief Number 33

    Treatment for Acute Pain: an Evidence Map Technical Brief Number 33

  • (12) United States Patent (10) Patent No.: US 9,072,728 B2 Rufo Et Al

    (12) United States Patent (10) Patent No.: US 9,072,728 B2 Rufo Et Al

  • Gastrointestinal Tract

    Gastrointestinal Tract

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • (CD-P-PH/PHO) Report Classification/Justifica

    (CD-P-PH/PHO) Report Classification/Justifica

  • Ep 2002846 B1

    Ep 2002846 B1

  • 2021 Equine Prohibited Substances List

    2021 Equine Prohibited Substances List

  • Pirprofen in Treatment of Non-Articular Rheumatism in Pakistani Outpatients, a Multicentre Study

    Pirprofen in Treatment of Non-Articular Rheumatism in Pakistani Outpatients, a Multicentre Study

  • Family Practice

    Family Practice

  • Anti-Inflammatory/Analgesic Combination of Alpha

    Anti-Inflammatory/Analgesic Combination of Alpha

  • (12) Patent Application Publication (10) Pub. No.: US 2011/0160273 A1 Buschmann Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2011/0160273 A1 Buschmann Et Al

  • Compositions, Methods and Devices for Generating Nanotubes on a Surface

    Compositions, Methods and Devices for Generating Nanotubes on a Surface

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • Marrakesh Agreement Establishing the World Trade Organization

    Marrakesh Agreement Establishing the World Trade Organization

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

Top View
  • Induced by Non-Steroidal Anti-Inflammatory Drugs (NSAID)
  • (12) Patent Application Publication (10) Pub. No.: US 2007/0077288A1 Klose Et Al
  • NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
  • FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
  • Customs Tariff - Schedule Xxi - 1
  • Wo 2007/044693 A2
  • WO 2015/067959 Al 14 May 2015 (14.05.2015) P O P C T
  • Contents Appendix 1A: List of Exposure Drugs in Nsaids and Pneumonia Analysis
  • United States Patent (19) 11 Patent Number: 6,096,728 Collins Et Al
  • PROSTAGLANDINS, NONSTEROIDAL ANTI-INFLAMMATORY AGENTS and EYE DISEASE* by Steven M
  • Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
  • Co-Crystals of Duloxetine and Co-Crystal Formers for the Treatment
  • FEI Prohibited Substances List 20Oct09-Sentnfs17dec09.Xlsx
  • JIA Guideline Appendix 4
  • Nonsteroidal Anti-Inflammatory Drugs in the Acute Treatment of Migraines
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Customs Tariff - Schedule Xxi - 1
  • Hepatitis Induced by Drugs


© 2024 Docslib.org    Feedback